
doi: 10.1002/ana.21206
pmid: 17721876
AbstractRecently, α‐aminoadipic semialdehyde (α‐AASA) dehydrogenase deficiency was shown to cause pyridoxine‐dependent epilepsy in a considerable number of patients. α‐AASA dehydrogenase deficiency is an autosomal recessive disorder characterized by a neonatal‐onset epileptic encephalopathy in which seizures are resistant to antiepileptic drugs but respond immediately to the administration of pyridoxine (OMIM 266100). Increased plasma and urinary levels of α‐AASA are associated with pathogenic mutations in the α‐AASA dehydrogenase (ALDH7A1/antiquitin) gene. Here, we report an intriguing “silent” mutation in ALDH7A1, a novel missense mutation and a founder mutation in a Dutch cohort (10 patients) with α‐AASA dehydrogenase deficiency. Ann Neurol 2007
Adult, Male, Heterozygote, Epilepsy, Aldehyde Dehydrogenase, Founder Effect, Mutation, Humans, Female, Genetic Predisposition to Disease, UMCN 3.1: Neuromuscular development and genetic disorders
Adult, Male, Heterozygote, Epilepsy, Aldehyde Dehydrogenase, Founder Effect, Mutation, Humans, Female, Genetic Predisposition to Disease, UMCN 3.1: Neuromuscular development and genetic disorders
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 58 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
